Literature DB >> 8807318

The development of ABO isohemagglutinins in Taiwanese.

Y J Liu1, W Chen, K W Wu, R E Broadberry, M Lin.   

Abstract

To evaluate the developmental pattern of ABO isohemagglutinins in Taiwanese, 644 blood samples (349 males, 295 females), including cord blood, were collected from individuals with ages ranging from newborn to 83 years. Synthesis of anti-A and anti-B could be demonstrated in most Taiwanese infants by 2-4 months of age, increasing progressively to reach adult levels (titers of 1:32-1:256) at around 1 year of age. Peak levels were reached at between 3-10 years of age and then declined with advancing years, with individuals of 80 years of age and over showing reduced levels similar to those seen in 6- to 12-month-old infants. Sex and parity did not appear to influence ABO isohemagglutinin development.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8807318     DOI: 10.1159/000154350

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  3 in total

Review 1.  ABO blood group and COVID-19: an updated systematic literature review and meta-analysis.

Authors:  Massimo Franchini; Mario Cruciani; Carlo Mengoli; Giuseppe Marano; Fabio Candura; Nadia Lopez; Ilaria Pati; Simonetta Pupella; Vincenzo De Angelis
Journal:  Blood Transfus       Date:  2021-05-12       Impact factor: 3.443

Review 2.  The Role of ABO Blood Type in Patients with SARS-CoV-2 Infection: A Systematic Review.

Authors:  Federico Banchelli; Pierpaolo Negro; Marcello Guido; Roberto D'Amico; Veronica Andrea Fittipaldo; Pierfrancesco Grima; Antonella Zizza
Journal:  J Clin Med       Date:  2022-05-27       Impact factor: 4.964

3.  Anti-A isohaemagglutinin titres and SARS-CoV-2 neutralization: implications for children and convalescent plasma selection.

Authors:  Daniele Focosi
Journal:  Br J Haematol       Date:  2020-07-08       Impact factor: 8.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.